• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早晨型生物节律降低女性乳腺癌患者化疗引起的周围神经病变风险。

Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer.

机构信息

Department of Neuropsychiatry, Dongguk University Ilsan Hospital, Goyang, Korea.

Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea.

出版信息

J Korean Med Sci. 2022 Feb 7;37(5):e34. doi: 10.3346/jkms.2022.37.e34.

DOI:10.3346/jkms.2022.37.e34
PMID:35132840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8822114/
Abstract

BACKGROUND

The purpose of this longitudinal prospective cohort study was to investigate the role of chronotype in the incidence of chemotherapy-induced peripheral neuropathy (CIPN) among women with breast cancer.

METHODS

We recruited women with breast cancer awaiting adjuvant chemotherapy, including four cycles of docetaxel. Participants reported peripheral neuropathy symptoms of numbness/tingling at the baseline, and at 4weeks after completion of chemotherapy. Candidate psychiatric factors associated with CIPN were assessed at the baseline, using the Composite Scale of Morningness, the Pittsburgh Sleep Quality Index, and the Hospital Anxiety and Depression Scale. To examine the association between chronotype and CIPN, we built logistic regression models, adjusting for demographic, clinical, and other psychiatric variables.

RESULTS

Among 48 participants, 29 participants developed CIPN. The morning chronotype was inversely associated with CIPN (odds ratio, 0.06; confidence interval, 0.01-0.74; = 0.028) after adjusting for age, BMI, education, type of operation, alcohol use, smoking, sleep quality, depression, and anxiety.

CONCLUSION

Our results suggest that the morning chronotype is a protective factor against the development of CIPN in patients with breast cancer who were treated with docetaxel.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT01887925.

摘要

背景

本纵向前瞻性队列研究旨在探讨时型在乳腺癌女性接受化疗引起的周围神经病变(CIPN)发生率中的作用。

方法

我们招募了等待辅助化疗的乳腺癌女性,包括四个周期的多西他赛。参与者在基线时和化疗结束后 4 周报告麻木/刺痛等周围神经病变症状。使用综合晨间型量表、匹兹堡睡眠质量指数和医院焦虑抑郁量表在基线时评估与 CIPN 相关的候选精神因素。为了研究时型与 CIPN 之间的关系,我们建立了逻辑回归模型,调整了人口统计学、临床和其他精神变量。

结果

在 48 名参与者中,有 29 名参与者出现 CIPN。在调整年龄、BMI、教育程度、手术类型、饮酒、吸烟、睡眠质量、抑郁和焦虑后,晨型与 CIPN 呈负相关(比值比,0.06;95%置信区间,0.01-0.74;P=0.028)。

结论

我们的结果表明,在接受多西他赛治疗的乳腺癌患者中,晨型是 CIPN 发展的保护因素。

试验注册

ClinicalTrials.gov 标识符:NCT01887925。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cb/8822114/89247a7251f3/jkms-37-e34-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cb/8822114/89247a7251f3/jkms-37-e34-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cb/8822114/89247a7251f3/jkms-37-e34-g001.jpg

相似文献

1
Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer.早晨型生物节律降低女性乳腺癌患者化疗引起的周围神经病变风险。
J Korean Med Sci. 2022 Feb 7;37(5):e34. doi: 10.3346/jkms.2022.37.e34.
2
Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer.晨型是保护绝经前乳腺癌女性免受化疗引起的潮热的因素。
Support Care Cancer. 2020 Mar;28(3):1351-1358. doi: 10.1007/s00520-019-04949-0. Epub 2019 Jul 1.
3
Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.预处理焦虑与接受新辅助化疗的乳腺癌女性患者中持续的化疗引起的周围神经病有关。
J Psychosom Res. 2018 May;108:14-19. doi: 10.1016/j.jpsychores.2018.02.012. Epub 2018 Feb 21.
4
Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.化疗诱导周围神经病变的炎症、行为、临床和心理社会危险因素的纵向研究。
Breast Cancer Res Treat. 2021 Sep;189(2):521-532. doi: 10.1007/s10549-021-06304-6. Epub 2021 Jun 30.
5
Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.紫杉烷类药物治疗新诊断乳腺癌幸存者化疗引起的周围神经病:一项前瞻性纵向研究。
Support Care Cancer. 2021 Jun;29(6):2959-2971. doi: 10.1007/s00520-020-05796-0. Epub 2020 Oct 6.
6
A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.乳腺癌女性患者化疗诱导周围神经病变的物理康复前瞻性监测模型。
Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463.
7
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.乳腺癌幸存者中长期化疗引起的周围神经病变:患病率、危险因素及跌倒风险。
Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10.
8
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.运动对化疗引起的周围神经病的影响:一项多中心随机对照试验。
Support Care Cancer. 2018 Apr;26(4):1019-1028. doi: 10.1007/s00520-017-4013-0. Epub 2017 Dec 14.
9
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.化疗引起的周围神经病变症状与跌倒风险的关联。
JAMA Neurol. 2016 Jul 1;73(7):860-6. doi: 10.1001/jamaneurol.2016.0383.
10
Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.化疗引起的乳腺癌女性外周神经病变的影响:基于不舒适症状理论的结构方程方法。
Cancer Nurs. 2021;44(2):145-153. doi: 10.1097/NCC.0000000000000764.

引用本文的文献

1
Relationship between BMI and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis.癌症患者体重指数与化疗引起的周围神经病变之间的关系:一项剂量反应荟萃分析。
World J Surg Oncol. 2025 Mar 8;23(1):77. doi: 10.1186/s12957-025-03716-2.

本文引用的文献

1
Circadian regulation of chemotherapy-induced peripheral neuropathic pain and the underlying transcriptomic landscape.生物钟对化疗诱导的周围神经病理性疼痛的调节作用及其潜在的转录组学特征。
Sci Rep. 2020 Aug 14;10(1):13844. doi: 10.1038/s41598-020-70757-w.
2
Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.紫杉醇诱导的癌症幸存者周围神经病变的表型特征。
J Pain Symptom Manage. 2018 Dec;56(6):908-919.e3. doi: 10.1016/j.jpainsymman.2018.08.017. Epub 2018 Aug 30.
3
Emerging relevance of circadian rhythms in headaches and neuropathic pain.
昼夜节律在头痛和神经病理性疼痛中的新兴相关性。
Acta Physiol (Oxf). 2019 Jan;225(1):e13161. doi: 10.1111/apha.13161. Epub 2018 Jul 25.
4
Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.预处理焦虑与接受新辅助化疗的乳腺癌女性患者中持续的化疗引起的周围神经病有关。
J Psychosom Res. 2018 May;108:14-19. doi: 10.1016/j.jpsychores.2018.02.012. Epub 2018 Feb 21.
5
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.韩国癌症统计数据:2015 年发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2018 Apr;50(2):303-316. doi: 10.4143/crt.2018.143. Epub 2018 Mar 21.
6
Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.晚睡型昼夜节律与乳腺癌女性新辅助化疗引起的恶心和呕吐有关。
Chronobiol Int. 2017;34(4):480-491. doi: 10.1080/07420528.2017.1295978. Epub 2017 Mar 31.
7
Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.化疗诱导的周围神经病变的长期影响、病理生理机制及危险因素:一项全面的文献综述
Front Pharmacol. 2017 Feb 24;8:86. doi: 10.3389/fphar.2017.00086. eCollection 2017.
8
Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.化疗引起的神经病变——患者和医疗保健提供者面临的日益严重的问题。
Brain Behav. 2016 Oct 26;7(1):e00558. doi: 10.1002/brb3.558. eCollection 2017 Jan.
9
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.乳腺癌幸存者中长期化疗引起的周围神经病变:患病率、危险因素及跌倒风险。
Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10.
10
Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer.乳腺癌患者睡眠质量差与化疗引起的恶心和呕吐的纵向关联。
Psychosom Med. 2016 Oct;78(8):959-965. doi: 10.1097/PSY.0000000000000372.